JP2008526752A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008526752A5 JP2008526752A5 JP2007549552A JP2007549552A JP2008526752A5 JP 2008526752 A5 JP2008526752 A5 JP 2008526752A5 JP 2007549552 A JP2007549552 A JP 2007549552A JP 2007549552 A JP2007549552 A JP 2007549552A JP 2008526752 A5 JP2008526752 A5 JP 2008526752A5
- Authority
- JP
- Japan
- Prior art keywords
- kit
- substituted
- amine
- irm
- ether
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64087304P | 2004-12-30 | 2004-12-30 | |
| PCT/US2005/047069 WO2006073940A2 (en) | 2004-12-30 | 2005-12-28 | Multi-route administration of immune response modifier compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008526752A JP2008526752A (ja) | 2008-07-24 |
| JP2008526752A5 true JP2008526752A5 (enExample) | 2009-02-19 |
Family
ID=36648022
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007549552A Withdrawn JP2008526752A (ja) | 2004-12-30 | 2005-12-28 | 免疫応答調節剤化合物の多経路投与 |
| JP2007549616A Ceased JP2008526757A (ja) | 2004-12-30 | 2005-12-28 | 免疫応答調節剤製剤および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007549616A Ceased JP2008526757A (ja) | 2004-12-30 | 2005-12-28 | 免疫応答調節剤製剤および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20080119508A1 (enExample) |
| EP (2) | EP1835915A4 (enExample) |
| JP (2) | JP2008526752A (enExample) |
| CN (1) | CN101443005A (enExample) |
| AU (2) | AU2005322843B2 (enExample) |
| CA (2) | CA2592575A1 (enExample) |
| WO (2) | WO2006074045A2 (enExample) |
| ZA (1) | ZA200706251B (enExample) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040265351A1 (en) | 2003-04-10 | 2004-12-30 | Miller Richard L. | Methods and compositions for enhancing immune response |
| AU2004266641A1 (en) | 2003-08-12 | 2005-03-03 | 3M Innovative Properties Company | Oxime substituted imidazo-containing compounds |
| EP1658076B1 (en) | 2003-08-27 | 2013-03-06 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
| US20050054665A1 (en) | 2003-09-05 | 2005-03-10 | 3M Innovative Properties Company | Treatment for CD5+ B cell lymphoma |
| KR20060120069A (ko) | 2003-10-03 | 2006-11-24 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | 피라졸로피리딘 및 그의 유사체 |
| ES2544477T3 (es) | 2003-10-03 | 2015-08-31 | 3M Innovative Properties Company | Imidazoquinolinas sustituidas con alcoxi |
| US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
| US7897767B2 (en) | 2003-11-14 | 2011-03-01 | 3M Innovative Properties Company | Oxime substituted imidazoquinolines |
| JP2007511535A (ja) | 2003-11-14 | 2007-05-10 | スリーエム イノベイティブ プロパティズ カンパニー | ヒドロキシルアミン置換イミダゾ環化合物 |
| RU2409576C2 (ru) | 2003-11-25 | 2011-01-20 | 3М Инновейтив Пропертиз Компани | Системы, содержащие имидазольное кольцо с заместителями, и способы их получения |
| WO2005066170A1 (en) | 2003-12-29 | 2005-07-21 | 3M Innovative Properties Company | Arylalkenyl and arylalkynyl substituted imidazoquinolines |
| CA2551399A1 (en) | 2003-12-30 | 2005-07-21 | 3M Innovative Properties Company | Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides |
| EP1730143A2 (en) | 2004-03-24 | 2006-12-13 | 3M Innovative Properties Company | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
| WO2005123080A2 (en) | 2004-06-15 | 2005-12-29 | 3M Innovative Properties Company | Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
| US8541438B2 (en) | 2004-06-18 | 2013-09-24 | 3M Innovative Properties Company | Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| WO2006065280A2 (en) | 2004-06-18 | 2006-06-22 | 3M Innovative Properties Company | Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods |
| WO2006009826A1 (en) | 2004-06-18 | 2006-01-26 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
| WO2006038923A2 (en) | 2004-06-18 | 2006-04-13 | 3M Innovative Properties Company | Aryl substituted imidazonaphthyridines |
| JP2008526752A (ja) * | 2004-12-30 | 2008-07-24 | スリーエム イノベイティブ プロパティズ カンパニー | 免疫応答調節剤化合物の多経路投与 |
| CA2592904C (en) | 2004-12-30 | 2015-04-07 | 3M Innovative Properties Company | Chiral fused [1,2]imidazo[4,5-c] ring compounds |
| AU2005326708C1 (en) | 2004-12-30 | 2012-08-30 | 3M Innovative Properties Company | Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds |
| US9248127B2 (en) | 2005-02-04 | 2016-02-02 | 3M Innovative Properties Company | Aqueous gel formulations containing immune response modifiers |
| WO2006086449A2 (en) | 2005-02-09 | 2006-08-17 | Coley Pharmaceutical Group, Inc. | Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines |
| JP2008530252A (ja) | 2005-02-09 | 2008-08-07 | コーリー ファーマシューティカル グループ，インコーポレイテッド | オキシムおよびヒドロキシルアミンで置換されたチアゾロ［４，５−ｃ］環化合物ならびに方法 |
| WO2006091394A2 (en) | 2005-02-11 | 2006-08-31 | Coley Pharmaceutical Group, Inc. | Substituted imidazoquinolines and imidazonaphthyridines |
| WO2006086634A2 (en) | 2005-02-11 | 2006-08-17 | Coley Pharmaceutical Group, Inc. | Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods |
| EP1851220A2 (en) | 2005-02-23 | 2007-11-07 | 3M Innovative Properties Company | Hydroxyalkyl substituted imidazonaphthyridines |
| WO2006098852A2 (en) | 2005-02-23 | 2006-09-21 | Coley Pharmaceutical Group, Inc. | Hydroxyalkyl substituted imidazoquinolines |
| JP2008538203A (ja) | 2005-02-23 | 2008-10-16 | コーリー ファーマシューティカル グループ，インコーポレイテッド | インターフェロンの生合成を優先的に誘導する方法 |
| EP1851218A2 (en) | 2005-02-23 | 2007-11-07 | 3M Innovative Properties Company | Hydroxyalkyl substituted imidazoquinoline compounds and methods |
| AU2006232375A1 (en) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases |
| US7943610B2 (en) | 2005-04-01 | 2011-05-17 | 3M Innovative Properties Company | Pyrazolopyridine-1,4-diamines and analogs thereof |
| EA200800782A1 (ru) | 2005-09-09 | 2008-08-29 | Коли Фармасьютикал Груп, Инк. | ПРОИЗВОДНЫЕ АМИДА И КАРБАМАТА N-{2-[4-АМИНО-2-(ЭТОКСИМЕТИЛ)-1Н-ИМИДАЗОЛО[4,5-c]ХИНОЛИН-1-IL]-1,1-ДИМЕТИЛЭТИЛ}МЕТАНСУЛЬФОНАМИДА И СПОСОБЫ |
| ZA200803029B (en) | 2005-09-09 | 2009-02-25 | Coley Pharm Group Inc | Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods |
| WO2007056112A2 (en) | 2005-11-04 | 2007-05-18 | Coley Pharmaceutical Group, Inc. | Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods |
| WO2007100634A2 (en) | 2006-02-22 | 2007-09-07 | 3M Innovative Properties Company | Immune response modifier conjugates |
| US8329721B2 (en) | 2006-03-15 | 2012-12-11 | 3M Innovative Properties Company | Hydroxy and alkoxy substituted 1H-imidazonaphthyridines and methods |
| US7906506B2 (en) | 2006-07-12 | 2011-03-15 | 3M Innovative Properties Company | Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods |
| WO2008030511A2 (en) | 2006-09-06 | 2008-03-13 | Coley Pharmaceuticial Group, Inc. | Substituted 3,4,6,7-tetrahydro-5h, 1,2a,4a,8-tetraazacyclopenta[cd]phenalenes |
| WO2010088924A1 (en) * | 2009-02-06 | 2010-08-12 | Telormedix Sa | Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration |
| MX2011010050A (es) | 2009-03-25 | 2011-12-14 | Univ Texas | Composiciones para estimulación de resistencia inmune innata de mamiferos a patógenos. |
| WO2011002776A1 (en) * | 2009-06-29 | 2011-01-06 | Nitric Biotherapeutics, Inc. | Pharmaceutical formulations for iontophoretic delivery of an immunomodulator |
| HRP20170433T1 (hr) | 2010-08-17 | 2017-05-05 | 3M Innovative Properties Company | Pripravci spoja za izmjenu lipidiranog imunološkog odgovora, formulacije, i postupci |
| CN103582496B (zh) | 2011-06-03 | 2016-05-11 | 3M创新有限公司 | 具有聚乙二醇链段的异双官能连接基以及由其制成的免疫应答调节剂缀合物 |
| WO2012167081A1 (en) | 2011-06-03 | 2012-12-06 | 3M Innovative Properties Company | Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom |
| CR20160214A (es) * | 2013-11-05 | 2016-10-11 | 3M Innovative Properties Co | Formulaciones de inyección con base en aceite de sésamo |
| WO2016019232A1 (en) | 2014-08-01 | 2016-02-04 | John Vasilakos | Methods and therapeutic combinations for treating tumors |
| WO2016044839A2 (en) | 2014-09-19 | 2016-03-24 | The Board Of Regents Of The University Of Texas System | Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds |
| US10533007B2 (en) | 2016-04-19 | 2020-01-14 | Innate Tumor Immunity, Inc. | NLRP3 modulators |
| MX2018012249A (es) | 2016-04-19 | 2019-02-07 | Innate Tumor Immunity Inc | Moduladores de nlpr3. |
| TWI674261B (zh) | 2017-02-17 | 2019-10-11 | 美商英能腫瘤免疫股份有限公司 | Nlrp3 調節劑 |
| EP3728255B1 (en) | 2017-12-20 | 2022-01-26 | 3M Innovative Properties Company | Amide substituted imidazo[4,5-c]quinoline compounds with a branched chain linking group for use as an immune response modifier |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA704419B (en) * | 1969-07-21 | 1971-04-28 | Ici Australia Ltd | Injectable aqueous solutions of tetramisole |
| DE2423389A1 (de) * | 1974-05-14 | 1975-12-04 | Hoechst Ag | Arzneimittel mit psychotroper wirkung und verfahren zu ihrer herstellung |
| US4826830A (en) * | 1985-07-31 | 1989-05-02 | Jui Han | Topical application of glyciphosphoramide |
| IL105325A (en) * | 1992-04-16 | 1996-11-14 | Minnesota Mining & Mfg | Immunogen/vaccine adjuvant composition |
| FR2732605B1 (fr) * | 1995-04-07 | 1997-05-16 | Pasteur Merieux Serums Vacc | Composition destinee a l'induction d'une reponse immunitaire mucosale |
| DE69834490T2 (de) * | 1997-05-29 | 2007-03-01 | Agresearch Ltd. | Verfahren zur herstellung von immunoglobulin a in milch |
| US6110929A (en) * | 1998-07-28 | 2000-08-29 | 3M Innovative Properties Company | Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| US6331539B1 (en) * | 1999-06-10 | 2001-12-18 | 3M Innovative Properties Company | Sulfonamide and sulfamide substituted imidazoquinolines |
| US6692745B2 (en) * | 2000-01-28 | 2004-02-17 | Arogenics Pharmaceuticals, Inc. | Compositions and methods for inhibition of HIV-1 infection |
| EP1478371A4 (en) * | 2001-10-12 | 2007-11-07 | Univ Iowa Res Found | METHOD AND PRODUCTS FOR IMPROVING IMMUNE RESPONSES WITH IMIDAZOCHINOLINE COMPOUNDS |
| US6677349B1 (en) * | 2001-12-21 | 2004-01-13 | 3M Innovative Properties Company | Sulfonamide and sulfamide substituted imidazoquinolines |
| GB0211649D0 (en) * | 2002-05-21 | 2002-07-03 | Novartis Ag | Organic compounds |
| EP1615665A4 (en) * | 2003-04-10 | 2010-10-06 | 3M Innovative Properties Co | DISTRIBUTION OF THE IMMUNE RESPONSE MODIFYING LINKS |
| MY157827A (en) * | 2003-06-27 | 2016-07-29 | 3M Innovative Properties Co | Sulfonamide substituted imidazoquinolines |
| AU2004264336B2 (en) * | 2003-08-05 | 2010-12-23 | 3M Innovative Properties Company | Formulations containing an immune response modifier |
| CU23404A1 (es) * | 2003-11-19 | 2009-08-04 | Ct Ingenieria Genetica Biotech | Polisacáridos capsulares de neisseria meningitidis como inmunopotenciadores mucosales y formulaciones resultantes |
| JP2008526752A (ja) * | 2004-12-30 | 2008-07-24 | スリーエム イノベイティブ プロパティズ カンパニー | 免疫応答調節剤化合物の多経路投与 |
-
2005
- 2005-12-28 JP JP2007549552A patent/JP2008526752A/ja not_active Withdrawn
- 2005-12-28 AU AU2005322843A patent/AU2005322843B2/en not_active Expired - Fee Related
- 2005-12-28 JP JP2007549616A patent/JP2008526757A/ja not_active Ceased
- 2005-12-28 WO PCT/US2005/047374 patent/WO2006074045A2/en not_active Ceased
- 2005-12-28 ZA ZA200706251A patent/ZA200706251B/xx unknown
- 2005-12-28 EP EP05855867A patent/EP1835915A4/en not_active Withdrawn
- 2005-12-28 CA CA002592575A patent/CA2592575A1/en not_active Abandoned
- 2005-12-28 US US11/722,585 patent/US20080119508A1/en not_active Abandoned
- 2005-12-28 EP EP05855599A patent/EP1830880A4/en not_active Withdrawn
- 2005-12-28 AU AU2005323024A patent/AU2005323024A1/en not_active Abandoned
- 2005-12-28 WO PCT/US2005/047069 patent/WO2006073940A2/en not_active Ceased
- 2005-12-28 CN CNA2005800488194A patent/CN101443005A/zh active Pending
- 2005-12-28 US US11/722,288 patent/US20080207674A1/en not_active Abandoned
- 2005-12-28 CA CA002592573A patent/CA2592573A1/en not_active Abandoned
-
2010
- 2010-09-29 US US12/894,032 patent/US20110021554A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008526752A5 (enExample) | ||
| US9248127B2 (en) | Aqueous gel formulations containing immune response modifiers | |
| US8221771B2 (en) | Formulations containing an immune response modifier | |
| AU2007345952C1 (en) | Positively charged water-soluble prodrugs of 1H-imidazo[4, 5-c]quinolin-4-amines and related compounds with very high skin penetration rates | |
| CA2361936C (en) | Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions | |
| ES2541132T3 (es) | Método para reducir y tratar la inmunosupresión inducida por UV-B | |
| AU2009210655B2 (en) | Treatment of bladder diseases with a TLR7 activator | |
| JP2007504145A5 (enExample) | ||
| JP2007521280A5 (enExample) | ||
| US20080119508A1 (en) | Multi-Route Administration Of Immune Response Modifier Compounds | |
| US20060216333A1 (en) | Methods related to the treatment of mucosal associated conditions | |
| RU2005138915A (ru) | Сульфонамид замещенные имидазохинолины | |
| JP2007503268A5 (enExample) | ||
| RU2003116063A (ru) | Сульфонамидоэфирзамещенные имидазохинолины | |
| AU2005244260A1 (en) | Methods, compositions, and preparations for delivery of immune response modifiers | |
| JP2007513165A (ja) | Ｉｒｍ化合物を含む併用薬および治療方法 | |
| JP2005517640A5 (enExample) | ||
| ES2291618T3 (es) | Composicion farmaceutica a base de un agente inhibidor de la pde4 o de la pde3/4 y de un agente antagonista de receptores de histamina. | |
| AU2003227710A1 (en) | New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders | |
| JP2008530014A (ja) | １−（２−メチルプロピル）−１Ｈ−イミダゾ［４，５−ｃ］［１，５］ナフチリジン−４−アミンを含む水性ゲル製剤 | |
| RU2024101306A (ru) | Применение соединения для получения лекарственного средства для лечения миелофиброза и сопутствующих симптомов/признаков, и применение указанного соединения | |
| HK1234056B (zh) | 1h-咪唑并[4，5-c]喹啉-4-胺类及其相关化合物的前药 | |
| NZ613313B2 (en) | Pharmaceutical formulation for topical administration comprising b220 | |
| NZ613313A (en) | Pharmaceutical formulation for topical administration comprising b220 |